Nath Bio-Genes (India) Ltd. (IN:NATHBIOGEN)
:NATHBIOGEN
Total Valuation
Nath Bio-Genes (India) Ltd. has a market cap or net worth of ₹2.84B. The enterprise value is ₹4.38B.
Market Cap₹2.84B
Enterprise Value₹4.38B
Share Statistics
Nath Bio-Genes (India) Ltd. has 19,004,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding19,004,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Nath Bio-Genes (India) Ltd.’s return on equity (ROE) is 0.06 and return on invested capital (ROIC) is 5.67%.
Return on Equity (ROE)0.06
Return on Assets (ROA)0.04
Return on Invested Capital (ROIC)5.67%
Return on Capital Employed (ROCE)0.07
Revenue Per Employee8.63M
Profits Per Employee912.52K
Employee Count423
Asset Turnover0.36
Inventory Turnover0.40
Valuation Ratios
The current PE Ratio of Nath Bio-Genes (India) Ltd. is 46.0. Nath Bio-Genes (India) Ltd.’s PEG ratio is -3.00.
PE Ratio46.0
PS Ratio0.82
PB Ratio0.47
Price to Fair Value0.47
Price to FCF31.02
Price to Operating Cash Flow-2.62
PEG Ratio-3.00
Income Statement
In the last 12 months, Nath Bio-Genes (India) Ltd. had revenue of 3.65B and earned 386.00M in profits. Earnings per share was 20.31.
Revenue3.65B
Gross Profit2.29B
Operating Income459.82M
Pretax Income400.44M
Net Income386.00M
EBITDA497.98M
Earnings Per Share (EPS)20.31
Cash Flow
In the last 12 months, operating cash flow was -1.09B and capital expenditures -11.04M, giving a free cash flow of -1.10B billion.
Operating Cash Flow-1.09B
Free Cash Flow-1.10B
Free Cash Flow per Share-57.77
Dividends & Yields
Nath Bio-Genes (India) Ltd. pays an annual dividend of ₹2, resulting in a dividend yield of 1.26%
Dividend Per Share₹2
Dividend Yield1.26%
Payout Ratio8.71%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.16
52-Week Price Change-0.71%
50-Day Moving Average144.69
200-Day Moving Average165.14
Relative Strength Index (RSI)59.86
Average Volume (3m)2.58K
Important Dates
Nath Bio-Genes (India) Ltd. upcoming earnings date is Jun 24, 2026, TBA (Confirmed).
Last Earnings DateJan 31, 2026
Next Earnings DateJun 24, 2026
Ex-Dividend Date―
Financial Position
Nath Bio-Genes (India) Ltd. as a current ratio of 1.89, with Debt / Equity ratio of 22.77%
Current Ratio1.89
Quick Ratio0.96
Debt to Market Cap0.41
Net Debt to EBITDA0.67
Interest Coverage Ratio4.39
Taxes
In the past 12 months, Nath Bio-Genes (India) Ltd. has paid 19.85M in taxes.
Income Tax19.85M
Effective Tax Rate0.05
Enterprise Valuation
Nath Bio-Genes (India) Ltd. EV to EBITDA ratio is 6.69, with an EV/FCF ratio of 34.50.
EV to Sales0.91
EV to EBITDA6.69
EV to Free Cash Flow34.50
EV to Operating Cash Flow18.96
Balance Sheet
Nath Bio-Genes (India) Ltd. has ₹1.59B in cash and marketable securities with ₹1.55B in debt, giving a net cash position of ₹40.40M billion.
Cash & Marketable Securities₹1.59B
Total Debt₹1.55B
Net Cash₹40.40M
Net Cash Per Share₹2.13
Tangible Book Value Per Share₹327.81
Margins
Gross margin is 48.97%, with operating margin of 12.60%, and net profit margin of 10.58%.
Gross Margin48.97%
Operating Margin12.60%
Pretax Margin10.97%
Net Profit Margin10.58%
EBITDA Margin13.65%
EBIT Margin12.60%
Analyst Forecast
The average price target for Nath Bio-Genes (India) Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast18.68%
EPS Growth Forecast16.47%